RiceBran Technologies (RIBT) 10-Q 3 Nov 22 2022 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 03, 2022
Document Information [Line Items]
Entity Central Index Key	0001063537
Entity Registrant Name	RiceBran Technologies
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-36245
Entity Incorporation, State or Country Code	CA
Entity Tax Identification Number	87-0673375
Entity Address, Address Line One	25420 Kuykendahl Rd., Suite B300
Entity Address, City or Town	Tomball
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77375
City Area Code	281
Local Phone Number	675-2421
Title of 12(b) Security	Common Stock, no par value per share
Trading Symbol	RIBT
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		6,242,077

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues	$ 10,252	$ 6,909	$ 31,001	$ 23,088
Cost of goods sold	10,949	7,185	31,673	22,539
Gross profit (loss)	(697)	(276)	(672)	549
Selling, general and administrative expenses	1,765	1,802	5,165	5,476
Loss (gain) on involuntary conversion of property and equipment	0	(1)	(147)	5
Operating loss	(2,462)	(2,077)	(5,690)	(4,932)
Interest income	7	0	9	1
Interest expense	(152)	(121)	(396)	(353)
Change in fair value of derivative warrant liability	612	0	24	0
Gain on extinguishment of PPP loan	0	0	0	1,792
Other expense	(39)	(18)	(111)	(55)
Other income	0	3	5	3
Loss before income taxes	(2,034)	(2,213)	(6,159)	(3,544)
Income tax expense	(8)	0	(20)	(1)
Net loss	$ (2,042)	$ (2,213)	$ (6,179)	$ (3,545)
Loss per common share:
Basic (in dollars per share)	$ (0.38)	$ (0.47)	$ (1.17)	$ (0.77)
Diluted (in dollars per share)	$ (0.38)	$ (0.47)	$ (1.17)	$ (0.77)
Weighted average number of shares outstanding:
Basic (in shares)	5,332,308	4,745,684	5,290,780	4,631,880
Diluted (in shares)	5,332,308	4,745,684	5,290,780	4,631,880

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 4,374	$ 5,825
Accounts receivable, net of allowance for doubtful accounts of $123 and $18	4,995	4,136
Inventories	2,687	2,444
Other current assets	1,148	810
Total current assets	13,204	13,215
Property and equipment, net	14,629	15,444
Operating lease right-of-use assets	1,868	2,127
Intangible assets	411	527
Total assets	30,112	31,313
Current liabilities:
Accounts payable	1,450	826
Commodities payable	1,960	1,702
Accrued salary, wages and benefits	908	787
Accrued expenses	941	683
Operating lease liabilities, current portion	417	382
Due under insurance premium finance agreements	429	128
Finance lease liabilities, current portion	130	86
Long-term debt, current portion	1,333	1,183
Total current liabilities	14,340	9,156
Operating lease liabilities, less current portion	1,613	1,948
Finance lease liabilities, less current portion	357	100
Long-term debt, less current portion	365	1,356
Derivative warrant liability	234	258
Total liabilities	16,909	12,818
Commitments and contingencies
Shareholders' equity:
Preferred stock, 20,000,000 shares authorized: Series G, convertible, 3,000 shares authorized, stated value $150, 150 shares, issued and outstanding	75	75
Common stock, no par value, 15,000,000 shares authorized, 5,242,077 shares and 5,158,967 shares, issued and outstanding	327,166	326,279
Accumulated deficit	(314,038)	(307,859)
Total shareholders' equity	13,203	18,495
Total liabilities and shareholders' equity	30,112	31,313
Line of Credit With Bank [Member]
Current liabilities:
Due under line of credit	1,846	0
Factoring Agreement [Member]
Current liabilities:
Due under line of credit	$ 4,926	$ 3,379

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Accounts receivable, allowance for doubtful accounts	$ 123	$ 18
Preferred stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	5,242,077	5,158,967
Common stock, shares outstanding (in shares)	5,242,077	5,158,967
Series G Preferred Stock [Member]
Preferred stock, shares authorized (in shares)	3,000	3,000
Preferred stock, stated value (in dollars per share)	$ 150	$ 150
Preferred stock, shares issued (in shares)	150	150
Preferred stock, shares outstanding (in shares)	150	150

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flow from operating activities:
Net loss	$ (6,179)	$ (3,545)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	1,575	1,821
Amortization	116	150
Stock and share-based compensation	887	840
Change in fair value derivative warrant liability	(24)	0
Loss (gain) on involuntary conversion of property and equipment	(147)	5
Gain on extinguishment of PPP loan	0	(1,792)
Provision for bad debts	105	13
Other	1	54
Changes in operating assets and liabilities:
Accounts receivable	(964)	(18)
Inventories	(243)	(295)
Accounts payable and accrued expenses	1,094	594
Commodities payable	258	619
Other	(338)	(431)
Net cash used in operating activities	(3,859)	(1,985)
Cash flows from investing activities:
Purchases of property and equipment	(411)	(1,187)
Proceeds from insurance on involuntary conversion	109	638
Net cash used in investing activities	(302)	(549)
Cash flows from financing activities:
Advances on factoring agreement, including the Over-advance	28,964	22,135
Payments on bank line of credit	(900)	0
Advances on insurance premium finance agreements	928	962
Payments on insurance premium finance agreements	(627)	(677)
Payments on long-term debt and finance lease liabilities	(963)	(534)
Proceeds from issuances of common stock and warrants, net of costs	0	3,372
Proceeds from common stock warrant exercises	0	171
Net cash provided by financing activities	2,710	3,459
Net change in cash and cash equivalents	(1,451)	925
Cash and cash equivalents, beginning of period	5,825	5,263
Cash and cash equivalents, end of period	4,374	6,188
Net change in cash and cash equivalents	(1,451)	925
Supplemental disclosures:
Cash paid for interest	354	267
Cash paid for income taxes	19	15
Factoring Agreement [Member]
Cash flows from financing activities:
Payments on factoring agreement	(27,417)	(21,970)
Line of Credit With Bank [Member]
Cash flows from financing activities:
Advances on factoring agreement, including the Over-advance	$ 2,725	$ 0

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. In the opinion of management, the accompanying unaudited condensed consolidated financial statements (interim financial statements) of RiceBran Technologies and its subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the rules and regulations of the Securities and Exchange Commission (the SEC) for reporting on Form 10 not These interim financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto in our Annual Report on Form 10 December 31, 2021, The results reported in these interim financial statements are not In August 2022, 1 August 26, 2022. Certain reclassifications have been made to amounts reported for the prior periods to achieve consistent presentation with the current period. Such reclassifications had no

Note 2 - Business

Note 2 - Business	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Nature of Operations [Text Block]	NOTE 2. We are a specialty ingredient company focused on the development, production, and marketing of products derived from traditional and ancient small grains. We create and produce products utilizing proprietary processes to deliver improved nutrition, ease of use, and extended shelf-life, while addressing consumer demand for all natural, non-GMO and organic products. We believe our products can become valuable alternatives to traditional food ingredients. Notably, we apply our proprietary technologies to convert raw rice bran into stabilized rice bran (SRB), and high value-added derivative products including: RiBalance, a rice bran nutritional package derived from SRB; RiSolubles, a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a fiber rich insoluble derivative of RiBalance and ProRyza, a rice bran protein-based product; and a variety of other valuable derivatives extracted from these core products. In granular form, SRB is a food additive used in products for human and animal consumption. We believe SRB has certain qualities that make it more attractive than additives based on the by-products of other agricultural commodities, such as corn, soybeans, wheat, and yeast. Our SRB products and SRB derivatives support the production of healthy, natural, hypoallergenic, gluten free, and non-genetically modified ingredients and supplements for use in meats, baked goods, cereals, coatings, health foods, and high-end animal nutrition. Our target customers are food and animal nutrition manufacturers, wholesalers and retailers, both domestically and internationally. We manufacture and distribute SRB from four locations: two facilities located within supplier-owned rice mills in Arbuckle and West Sacramento, California; one company-owned facility in Mermentau, Louisiana; and our own rice mill in Wynne, Arkansas. At our Dillon, Montana facility, we produce SRB-based products and derivatives through proprietary processes. Our rice mill in Wynne, Arkansas (Golden Ridge) supplies grades U.S. No. 1 No. 2

Note 3 - Summary of Significant

Note 3 - Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 3. Recent accounting standards not The following discusses the accounting standard(s) not In June 2016, No. 2016 13 326 2023 January 1, 2023. not

Note 4 - Cash and Cash Equivale

Note 4 - Cash and Cash Equivalents	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Cash and Cash Equivalents Disclosure [Text Block]	NOTE 4. As of September 30, 2022, three We have cash on deposit in excess of federally insured limits at a bank. We do not

Note 5 - Accounts Receivable an

Note 5 - Accounts Receivable and Revenues	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Accounts Receivable and Revenues [Text Block}	NOTE 5. Amounts billed and due from our customers are classified as accounts receivable on our consolidated balance sheets and require payment on a short-term basis. Invoices are generally issued at the point control transfers and substantially all of our invoices are due within 30 120 30 three nine September 30, 2022 2021, Our accounts receivable potentially subject us to significant concentrations of credit risk. Revenues and accounts receivable from significant customers (customers with revenue or accounts receivable in excess of 10% Customer A B C D % of revenues, three months ended September 30, 2022 15 % 5 % 11 % - % % of revenues, three months ended September 30, 2021 21 % 7 % - % 9 % % of revenues, nine months ended September 30, 2022 13 % 8 % 5 % 2 % % of revenues, nine months ended September 30, 2021 10 % 11 % 1 % 11 % % of accounts receivable, as of September 30, 2022 13 % 7 % 17 % - % % of accounts receivable, as of December 31, 2021 15 % 8 % - % 9 % The following table presents revenues by geographic area shipped to (in thousands). Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 United States $ 9,876 $ 6,450 $ 30,034 $ 21,867 Other countries 376 459 967 1,221 Revenues $ 10,252 $ 6,909 $ 31,001 $ 23,088

Note 6 - Property and Equipment

Note 6 - Property and Equipment	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 6. The following table details the components of property and equipment (amounts in thousands). September 30, December 31 2022 2021 Estimated Useful Lives Land $ 730 $ 730 Furniture and fixtures 259 265 5 - 10 years Plant 10,094 10,457 20 - 40 years, or life of lease Computer and software 450 452 3 - 5 years Leasehold improvements 1,838 1,828 4 - 15 years, or life of lease Machinery and equipment 15,598 15,115 5 - 15 years Property and equipment, cost 28,969 28,847 Less accumulated depreciation 14,340 13,403 Property and equipment, net $ 14,629 $ 15,444 Amounts payable for property and equipment included in accounts payable totaled $0.1 million at September 30, 2022, December 31, 2021. not September 30, 2022, December 31, 2021.

Note 7 - Leases

Note 7 - Leases	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Lessee, Operating and Finance Leases [Text Block]	NOTE 7. The components of lease expense and cash flows from leases (in thousands) follow. Three Months Ended September 30, Nine Months Ended Setepmber 30, 2022 2021 2022 2021 Finance lease cost: Amortization of right-of use assets, included in cost of goods sold $ 20 $ 24 $ 59 $ 67 Interest on lease liabilities 6 2 11 8 Operating lease cost, included in selling, general and administrative expenses: Fixed leases cost 129 129 387 387 Variable lease cost 39 37 125 112 Short-term lease cost 41 21 62 60 Total lease cost $ 235 $ 213 $ 644 $ 634 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from finance leases $ 6 $ 2 $ 11 $ 8 Operating cash flows from operating leases $ 129 $ 129 $ 387 $ 387 Financing cash flows from finance leases $ 22 $ 23 $ 68 $ 73 As of September 30, 2022, not September 30, 2022, December 31, 2021, September 30, 2022, December 31, 2021. three nine September 30, 2022, three nine September 30, 2021, As of September 30, 2022, not September 30, 2022, Operating Leases Finance Leases Remaining leases terms (in years) 1.0 - 10.4 0.4 - 5.0 Weighted average remaining lease terms (in years) 5.7 3.0 Discount rates 6.3% - 9.0% 2.8% - 10.4% Weighted average discount rate 7.8% 8.1% Maturities of lease liabilities as of September 30, 2022, Operating Finance Leases Leases 2022 (three months ended December 31, 2022) $ 122 $ 52 2023 528 158 2024 429 117 2025 440 102 2026 450 100 Thereafter 578 60 Total lease payments 2,547 589 Amounts representing interest (517 ) (102 ) Present value of lease obligations $ 2,030 $ 487

Note 8 - Debt

Note 8 - Debt	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 8. We finance certain amounts owed for annual insurance premiums under financing agreements. As of September 30, 2022, March 2023, We borrow under a factoring agreement with a lender (the Lender), which provides a $7.0 million credit facility. We may two October 2023. two October 2021. no The Lender advanced us $0.9 million effective September 30, 2022 ( September 30, 2022). December 29, 2022. Additional information related to our factoring obligation (exclusive of the Over-advance) follows. Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Average borrowings outstanding (in thousands) $ 3,150 $ 1,522 $ 3,036 $ 1,324 Amortization of debt issuance costs (in thousands) $ - $ 23 $ - $ 68 Interest paid, as a percentage of average outstanding borrowings 1.6 % 2.0 % 1.4 % 5.0 % Fees paid, as a percentage of average outstanding borrowings 1.6 % 1.6 % 1.2 % 5.0 % As of September 30, 2022, September 30, 2022). no three September 30, 2022, nine September 30, 2022. RiceBran Technologies Notes to Unaudited Condensed Consolidated Financial Statements Long-term debt consists of the following (in thousands). September 30, December 31, 2022 2021 Mortgage promissory note - Originally dated July 2020 and modified in December 2021. As modified, interest accrues at an annual rate which is the greater of 7.0 10.3 13.3 December 2023 11 2.5 $ 1,614 $ 2,469 Progress payment agreement - Dated August 2022. Original principal $ 37 25.2 November 2022 37 - Equipment note - Dated May 2021. Original principal $ 46 June 2025 3.6 27 33 Equipment note - Dated December 2019. Original principal $ 40 December 2024 9.3 20 26 Equipment note - Initially recorded in November 2018, in an acquisition, at the present value of future payments using a discount rate of 4.8 August 2022 - 11 Total long-term debt, net $ 1,698 $ 2,539 Future principal maturities of long-term debt outstanding as of September 30, 2022, 2022 (three months ended December 31, 2022) $ 347 2023 1,337 2024 19 2025 5 Principal maturities 1,708 Debt issuance costs (10 ) Total long-term debt, net $ 1,698

Note 9 - Equity, Share-based Co

Note 9 - Equity, Share-based Compensation and Warrants	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Shareholders' Equity and Share-Based Payments [Text Block]	NOTE 9. In August 2022, 1 10 August 26, 2022. On July 14, 2022, 2014 2014 September 30, 2022, 2014 A summary of equity activity follows (in thousands, except share amounts). Shares Preferred Preferred Common Accumulated Series G Common Stock Stock Deficit Equity Balance, December 31, 2021 150 5,158,967 $ 75 $ 326,279 $ (307,859 ) $ 18,495 Common stock awards under equity incentive plans - 22,475 - 241 - 241 Common stock issued to vendor - 600 - 5 - 5 Net income - - - - (1,516 ) (1,516 ) Balance, March 31, 2022 150 5,182,042 75 326,525 (309,375 ) 17,225 Common stock awards under equity incentive plans - 48,388 - 146 - 146 Common stock issued to vendor - 600 - 1 - 1 Net loss - - - - (2,621 ) (2,621 ) Balance, June 30, 2022 150 5,231,030 75 326,672 (311,996 ) 14,751 Common stock awards under equity incentive plans - - 492 - 492 Common stock issued to vendor - 600 - 2 - 2 Other - 10,447 - - - - Net loss - - - - (2,042 ) (2,042 ) Balance, September 30, 2022 150 5,242,077 $ 75 $ 327,166 $ (314,038 ) $ 13,203 Shares Preferred Preferred Common Accumulated Series G Common Stock Stock Deficit Equity Balance, December 31, 2020 225 4,523,809 $ 112 $ 322,218 $ (298,910 ) $ 23,420 Common stock awards under equity incentive plans - 2,994 - 250 - 250 Common stock issued to vendor - 600 - 3 - 3 Other - - - (3 ) - (3 ) Net income - - - - 591 591 Balance, March 31, 2021 225 4,527,403 112 322,468 (298,319 ) 24,261 Common stock awards under equity incentive plans - 2,964 - 290 - 290 Common stock issued to vendor - 600 - 5 - 5 Exercise of common stock warrants - 17,794 - 171 - 171 Other - - - 3 - 3 Net loss - - - - (1,923 ) (1,923 ) Balance, June 30, 2021 225 4,548,761 112 322,937 (300,242 ) 22,807 Common stock awards under equity incentive plans - 38,978 - 287 - 287 Common stock issued to vendor - 600 - 5 - 5 Sale of common stock and common stock warrants, net of costs - 3,062,395 - 2,725 - 2,725 Exercise of common stock warrant - 1,500,000 - - - - Conversion of preferred stock into common stock (75 ) 71,174 (37 ) 37 - - Net loss - - - - (2,213 ) (2,213 ) Balance, September 30, 2021 150 9,221,908 $ 75 $ 325,991 $ (302,455 ) $ 23,611 Share-based compensation by type of award follows (in thousands). Three Months Ended September 30, 2022 June 30, 2022 March 31, 2022 Stock options $ 28 $ 21 $ 29 Restricted stock units 464 125 212 Compensation expense related to common stock awards issued under equity incentive plan $ 492 $ 146 $ 241 Options In the three September 30, 2022, three June 30, 2022, three March 31, 2022, Stock Units We have outstanding (i) restricted stock units (RSUs) issued under the 2014 one Restricted Stock Units (Issued under 2014 Plan) Stock Units Issued to Vendors Number of Units Unrecognized Stock Compensation (in thousands) Weighted Average Expense Period (Years) Number of Units Unrecognized Stock Compensation (in thousands) Weighted Average Expense Period (Years) Nonvested at December 31, 2021 126,603 $ (658 ) 0.9 - $ - - Granted 37,000 (153 ) 2.0 - - - Forfeited (1,000 ) 7 0.7 - - - Vested with service (22,475 ) - - - - - Expensed - 212 - - - - Nonvested at March 31, 2022 140,128 (592 ) 0.9 - - - Impact of Modification: - - - Before modification (11,468 ) 125 - - - - After modification 11,468 (60 ) - - - - Forfeited (9,454 ) 55 - - - - Vested with Service (34,404 ) - - - - - Expensed - 125 - - - - Nonvested at June 30, 2022 96,270 (347 ) 0.9 - - - Granted 402,276 (1,458 ) 2.8 38,968 (65 ) 3.0 Vested with Service (63,607 ) - - - - - Expensed - 464 - - - - Nonvested at September 30, 2022 434,939 $ (1,341 ) 2.5 38,968 $ (65 ) 3.0 Number of RSUs Vested at December 31, 2021 86,505 Vested with service 22,475 Issued at vesting (22,475 ) Vested at March 31, 2022 86,505 Vested with service 34,404 Issued at termination of service (48,386 ) Vested at June 30, 2022 72,523 Vested with service 63,607 Vested at September 30, 2022 136,130 As of September 30, 2022, no In the three September 30, 2022, 2014 ● 278,151 RSUs, the issuance of which was subject to shareholder approval of the increase in the shares of common stock authorized for issuance under the 2014 forty-nine July 14, 2022, ● 65,790 RSUs to our directors which vest on July 14, 2023, one ● 19,003 RSUs to our directors on July 14, 2022, June 30, 2022. ● 30,279 RSUs to our directors on September 30, 2022, September 30, 2022. ● 9,053 RSUs to employees. The RSUs vest over an average of 8 months from the date of grant. We issued 38,968 SUs to a service provider in September 2022 November 2022, three September 2025, three may October 1, 2022, may 90 38,968 121,032 may not In April 2022, April 28, 2022, In the three June 30, 2022, no three March 31, 2022, Warrants In the three September 30, 2022, 12, three March 31, 2022, Subsequent Offering In October 2022, April 20, 2023, October 20, 2025. October 20, 2022, may In addition, we issued warrants for the purchase of up to 63,000 shares of our common stock to the placement agent at an exercise price of $1.875 per share, which expire October 20, 2027.

Note 10 - Income Taxes

Note 10 - Income Taxes	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 10. Our tax expense for the three nine September 30, 2022 2021, no September 30, 2022, not not

Note 11 - Loss Per Share (EPS)

Note 11 - Loss Per Share (EPS)	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Earnings Per Share [Text Block]	NOTE 11. We calculate basic EPS under the two may not We calculate diluted EPS by dividing the net income attributable to RiceBran Technologies common shareholders by the weighted average number of common shares outstanding during the period increased by the number of additional common shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive. We calculate the dilutive effects of outstanding options, warrants, and nonvested stock units that vest solely on the basis of a service condition are calculated using the treasury stock method. We calculate the dilutive effects of the outstanding preferred stock using the if-converted method. Reconciliations of the numerators and denominators in the EPS computations follow. Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 NUMERATOR (in thousands): Numerator for basic and diluted EPS - net loss $ (2,042 ) $ (2,213 ) $ (6,179 ) $ (3,545 ) DENOMINATOR: Weighted average number of shares of shares of common stock outstanding 5,235,005 4,662,004 5,203,504 4,575,587 Weighted average number of shares of common stock underlying vested RSUs 97,303 83,680 87,276 56,293 Denominator for basic and diluted EPS - weighted average number of shares outstanding 5,332,308 4,745,684 5,290,780 4,631,880 No three nine September 30, 2022 2021, three nine September 30, 2022 2021,

Note 12 - Fair Value Measuremen

Note 12 - Fair Value Measurements	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Fair Value Disclosures [Text Block]	NOTE 12. The fair value of cash and cash equivalents, accounts and other receivables, accounts payable and commodities payable approximates their carrying value due to shorter maturities. As of September 30, 2022, 3 September 30, 2022, 3 The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our consolidated balance sheets (in thousands): Level 1 Level 2 Level 3 Total Total liabilities at fair value as of September 30, 2022 - Derivative warrant liability $ - $ - $ 234 $ 234 Total liabilities at fair value as of December 31, 2021 - Derivative warrant liability $ - $ - $ 258 $ 258 Total liabilities at fair value as of September 30, 2021 - Derivative warrant liability $ - $ - $ 647 $ 647 The following tables summarize the changes in level 3 three nine September 30, 2022 2021 Fair Value as of Beginning of Period Total Realized and Unrealized Gains (Losses) Issuance of New Instruments Net Transfers (Into) Out of Level 3 Fair Value, at End of Period Change in Unrealized Gains (Losses) on Instruments Still Held Three months ended September 30, 2022 Total Level 3 fair value - Derivative warrant liability $ 846 $ 612 $ - $ - $ 234 $ 612 Nine months ended September 30, 2022: Total Level 3 fair value - Derivative warrant liability $ 258 $ 24 $ - $ - $ 234 $ 24 Three and nine months ended September 30, 2021 Total Level 3 fair value - Derivative warrant liability $ - $ - $ 647 $ - $ 647 $ - The derivative warrant liability relates to a warrant issued in September 2021, September 2023 5 September 2022 may September 30, 2022, December 31, 2021, September 30, 2022 December 31, 2021 Assumed volatility 88.3 % 69.5 % Assumed risk free interest rate 3.2 % 0.8 % Expected life of options (in years) 4.0 4.8 Expected dividends - - The fair value of Warrant A approximates the cash settlement the holder could elect to be paid in the event of a change in control. At September 30, 2022,

Note 13 - Commitments and Conti

Note 13 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 13. PPP Audit Contingency In April 2020, March 2020. January 2021. may January 2027, six may 2020 $2 RiceBran Technologies Notes to Unaudited Condensed Consolidated Financial Statements Employment Contracts and Severance Payments In the normal course of business, we periodically enter into employment agreements which incorporate indemnification provisions. While the maximum amount to which we may No We have employment contracts with certain officers and key management that include provisions for potential severance payments in the event of without-cause terminations or terminations under certain circumstances after a change in control. In addition, vesting of outstanding nonvested equity grants would accelerate following a change in control. Legal Matters From time to time, we are involved in litigation incidental to the conduct of our business. These matters may no

Note 14 - Failure to Comply wit

Note 14 - Failure to Comply with NASDAQ Listing Requirements	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Failure to Comply with Nasdaq Listing Requirements Disclosure [Text Block]	NOTE 14. On September 15, 2021, 5550 2 5550 2 $1.00. $1.00 10, not 20, September 12, 2022,

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recent accounting standards not The following discusses the accounting standard(s) not In June 2016, No. 2016 13 326 2023 January 1, 2023. not

Note 5 - Accounts Receivable _2

Note 5 - Accounts Receivable and Revenues (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Customer A B C D % of revenues, three months ended September 30, 2022 15 % 5 % 11 % - % % of revenues, three months ended September 30, 2021 21 % 7 % - % 9 % % of revenues, nine months ended September 30, 2022 13 % 8 % 5 % 2 % % of revenues, nine months ended September 30, 2021 10 % 11 % 1 % 11 % % of accounts receivable, as of September 30, 2022 13 % 7 % 17 % - % % of accounts receivable, as of December 31, 2021 15 % 8 % - % 9 %
Disaggregation of Revenue [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 United States $ 9,876 $ 6,450 $ 30,034 $ 21,867 Other countries 376 459 967 1,221 Revenues $ 10,252 $ 6,909 $ 31,001 $ 23,088

Note 6 - Property and Equipme_2

Note 6 - Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Property, Plant and Equipment [Table Text Block]	September 30, December 31 2022 2021 Estimated Useful Lives Land $ 730 $ 730 Furniture and fixtures 259 265 5 - 10 years Plant 10,094 10,457 20 - 40 years, or life of lease Computer and software 450 452 3 - 5 years Leasehold improvements 1,838 1,828 4 - 15 years, or life of lease Machinery and equipment 15,598 15,115 5 - 15 years Property and equipment, cost 28,969 28,847 Less accumulated depreciation 14,340 13,403 Property and equipment, net $ 14,629 $ 15,444

Note 7 - Leases (Tables)

Note 7 - Leases (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Lease, Cost [Table Text Block]	Three Months Ended September 30, Nine Months Ended Setepmber 30, 2022 2021 2022 2021 Finance lease cost: Amortization of right-of use assets, included in cost of goods sold $ 20 $ 24 $ 59 $ 67 Interest on lease liabilities 6 2 11 8 Operating lease cost, included in selling, general and administrative expenses: Fixed leases cost 129 129 387 387 Variable lease cost 39 37 125 112 Short-term lease cost 41 21 62 60 Total lease cost $ 235 $ 213 $ 644 $ 634 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from finance leases $ 6 $ 2 $ 11 $ 8 Operating cash flows from operating leases $ 129 $ 129 $ 387 $ 387 Financing cash flows from finance leases $ 22 $ 23 $ 68 $ 73
Lessee, Operating and Finance Leases, Remaining Terms and Discount Rates [Table Text Block]	Operating Leases Finance Leases Remaining leases terms (in years) 1.0 - 10.4 0.4 - 5.0 Weighted average remaining lease terms (in years) 5.7 3.0 Discount rates 6.3% - 9.0% 2.8% - 10.4% Weighted average discount rate 7.8% 8.1%
Lessee, Operating and Finance Lease Liability, Maturity [Table Text Block]	Operating Finance Leases Leases 2022 (three months ended December 31, 2022) $ 122 $ 52 2023 528 158 2024 429 117 2025 440 102 2026 450 100 Thereafter 578 60 Total lease payments 2,547 589 Amounts representing interest (517 ) (102 ) Present value of lease obligations $ 2,030 $ 487

Note 8 - Debt (Tables)

Note 8 - Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Debt [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Average borrowings outstanding (in thousands) $ 3,150 $ 1,522 $ 3,036 $ 1,324 Amortization of debt issuance costs (in thousands) $ - $ 23 $ - $ 68 Interest paid, as a percentage of average outstanding borrowings 1.6 % 2.0 % 1.4 % 5.0 % Fees paid, as a percentage of average outstanding borrowings 1.6 % 1.6 % 1.2 % 5.0 %
Schedule of Long-Term Debt Instruments [Table Text Block]	September 30, December 31, 2022 2021 Mortgage promissory note - Originally dated July 2020 and modified in December 2021. As modified, interest accrues at an annual rate which is the greater of 7.0 10.3 13.3 December 2023 11 2.5 $ 1,614 $ 2,469 Progress payment agreement - Dated August 2022. Original principal $ 37 25.2 November 2022 37 - Equipment note - Dated May 2021. Original principal $ 46 June 2025 3.6 27 33 Equipment note - Dated December 2019. Original principal $ 40 December 2024 9.3 20 26 Equipment note - Initially recorded in November 2018, in an acquisition, at the present value of future payments using a discount rate of 4.8 August 2022 - 11 Total long-term debt, net $ 1,698 $ 2,539
Schedule of Maturities of Long-Term Debt [Table Text Block]	2022 (three months ended December 31, 2022) $ 347 2023 1,337 2024 19 2025 5 Principal maturities 1,708 Debt issuance costs (10 ) Total long-term debt, net $ 1,698

Note 9 - Equity, Share-based _2

Note 9 - Equity, Share-based Compensation and Warrants (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Stockholders Equity [Table Text Block]	Shares Preferred Preferred Common Accumulated Series G Common Stock Stock Deficit Equity Balance, December 31, 2021 150 5,158,967 $ 75 $ 326,279 $ (307,859 ) $ 18,495 Common stock awards under equity incentive plans - 22,475 - 241 - 241 Common stock issued to vendor - 600 - 5 - 5 Net income - - - - (1,516 ) (1,516 ) Balance, March 31, 2022 150 5,182,042 75 326,525 (309,375 ) 17,225 Common stock awards under equity incentive plans - 48,388 - 146 - 146 Common stock issued to vendor - 600 - 1 - 1 Net loss - - - - (2,621 ) (2,621 ) Balance, June 30, 2022 150 5,231,030 75 326,672 (311,996 ) 14,751 Common stock awards under equity incentive plans - - 492 - 492 Common stock issued to vendor - 600 - 2 - 2 Other - 10,447 - - - - Net loss - - - - (2,042 ) (2,042 ) Balance, September 30, 2022 150 5,242,077 $ 75 $ 327,166 $ (314,038 ) $ 13,203 Shares Preferred Preferred Common Accumulated Series G Common Stock Stock Deficit Equity Balance, December 31, 2020 225 4,523,809 $ 112 $ 322,218 $ (298,910 ) $ 23,420 Common stock awards under equity incentive plans - 2,994 - 250 - 250 Common stock issued to vendor - 600 - 3 - 3 Other - - - (3 ) - (3 ) Net income - - - - 591 591 Balance, March 31, 2021 225 4,527,403 112 322,468 (298,319 ) 24,261 Common stock awards under equity incentive plans - 2,964 - 290 - 290 Common stock issued to vendor - 600 - 5 - 5 Exercise of common stock warrants - 17,794 - 171 - 171 Other - - - 3 - 3 Net loss - - - - (1,923 ) (1,923 ) Balance, June 30, 2021 225 4,548,761 112 322,937 (300,242 ) 22,807 Common stock awards under equity incentive plans - 38,978 - 287 - 287 Common stock issued to vendor - 600 - 5 - 5 Sale of common stock and common stock warrants, net of costs - 3,062,395 - 2,725 - 2,725 Exercise of common stock warrant - 1,500,000 - - - - Conversion of preferred stock into common stock (75 ) 71,174 (37 ) 37 - - Net loss - - - - (2,213 ) (2,213 ) Balance, September 30, 2021 150 9,221,908 $ 75 $ 325,991 $ (302,455 ) $ 23,611
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended September 30, 2022 June 30, 2022 March 31, 2022 Stock options $ 28 $ 21 $ 29 Restricted stock units 464 125 212 Compensation expense related to common stock awards issued under equity incentive plan $ 492 $ 146 $ 241
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]	Restricted Stock Units (Issued under 2014 Plan) Stock Units Issued to Vendors Number of Units Unrecognized Stock Compensation (in thousands) Weighted Average Expense Period (Years) Number of Units Unrecognized Stock Compensation (in thousands) Weighted Average Expense Period (Years) Nonvested at December 31, 2021 126,603 $ (658 ) 0.9 - $ - - Granted 37,000 (153 ) 2.0 - - - Forfeited (1,000 ) 7 0.7 - - - Vested with service (22,475 ) - - - - - Expensed - 212 - - - - Nonvested at March 31, 2022 140,128 (592 ) 0.9 - - - Impact of Modification: - - - Before modification (11,468 ) 125 - - - - After modification 11,468 (60 ) - - - - Forfeited (9,454 ) 55 - - - - Vested with Service (34,404 ) - - - - - Expensed - 125 - - - - Nonvested at June 30, 2022 96,270 (347 ) 0.9 - - - Granted 402,276 (1,458 ) 2.8 38,968 (65 ) 3.0 Vested with Service (63,607 ) - - - - - Expensed - 464 - - - - Nonvested at September 30, 2022 434,939 $ (1,341 ) 2.5 38,968 $ (65 ) 3.0 Number of RSUs Vested at December 31, 2021 86,505 Vested with service 22,475 Issued at vesting (22,475 ) Vested at March 31, 2022 86,505 Vested with service 34,404 Issued at termination of service (48,386 ) Vested at June 30, 2022 72,523 Vested with service 63,607 Vested at September 30, 2022 136,130

Note 11 - Loss Per Share (EPS)

Note 11 - Loss Per Share (EPS) (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 NUMERATOR (in thousands): Numerator for basic and diluted EPS - net loss $ (2,042 ) $ (2,213 ) $ (6,179 ) $ (3,545 ) DENOMINATOR: Weighted average number of shares of shares of common stock outstanding 5,235,005 4,662,004 5,203,504 4,575,587 Weighted average number of shares of common stock underlying vested RSUs 97,303 83,680 87,276 56,293 Denominator for basic and diluted EPS - weighted average number of shares outstanding 5,332,308 4,745,684 5,290,780 4,631,880

Note 12 - Fair Value Measurem_2

Note 12 - Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	Level 1 Level 2 Level 3 Total Total liabilities at fair value as of September 30, 2022 - Derivative warrant liability $ - $ - $ 234 $ 234 Total liabilities at fair value as of December 31, 2021 - Derivative warrant liability $ - $ - $ 258 $ 258 Total liabilities at fair value as of September 30, 2021 - Derivative warrant liability $ - $ - $ 647 $ 647
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Fair Value as of Beginning of Period Total Realized and Unrealized Gains (Losses) Issuance of New Instruments Net Transfers (Into) Out of Level 3 Fair Value, at End of Period Change in Unrealized Gains (Losses) on Instruments Still Held Three months ended September 30, 2022 Total Level 3 fair value - Derivative warrant liability $ 846 $ 612 $ - $ - $ 234 $ 612 Nine months ended September 30, 2022: Total Level 3 fair value - Derivative warrant liability $ 258 $ 24 $ - $ - $ 234 $ 24 Three and nine months ended September 30, 2021 Total Level 3 fair value - Derivative warrant liability $ - $ - $ 647 $ - $ 647 $ -
Warrants, Valuation Assumption [Table Text Block]	September 30, 2022 December 31, 2021 Assumed volatility 88.3 % 69.5 % Assumed risk free interest rate 3.2 % 0.8 % Expected life of options (in years) 4.0 4.8 Expected dividends - -

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation (Details Textual)	Aug. 26, 2022
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio	10

Note 2 - Business (Details Text

Note 2 - Business (Details Textual)	9 Months Ended
	Sep. 30, 2022
Number of Reporting Units	1
Number of Operating Segments	1
Stabilized Rice Bran (SRB) [Member]
Number of Manufacturing and Distribution Locations	4
Stabilized Rice Bran (SRB) [Member] | CALIFORNIA
Number of Manufacturing and Distribution Locations	2
Stabilized Rice Bran (SRB) [Member] | LOUISIANA
Number of Manufacturing and Distribution Locations	1

Note 4 - Cash and Cash Equiva_2

Note 4 - Cash and Cash Equivalents (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Cash and Cash Equivalents, at Carrying Value, Total	$ 4,374	$ 5,825
Money Market Funds [Member]
Cash and Cash Equivalents, at Carrying Value, Total	$ 2,700

Note 5 - Accounts Receivable _3

Note 5 - Accounts Receivable and Revenues (Details Textual) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Contract with Customer, Liability, Total	$ 0.1	$ 0.1

Note 5 - Accounts Receivable _4

Note 5 - Accounts Receivable and Revenues - Revenues and Accounts Receivable from Significant Customers (Details) - Customer Concentration Risk [Member]	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Revenue Benchmark [Member] | Customer A [Member]
Concentration risk, percentage	15%	21%	13%	10%
Revenue Benchmark [Member] | Customer B [Member]
Concentration risk, percentage	5%	7%	8%	11%
Revenue Benchmark [Member] | Customer C [Member]
Concentration risk, percentage	11%	0%	5%	1%
Revenue Benchmark [Member] | Customer D [Member]
Concentration risk, percentage	0%	9%	2%	11%
Accounts Receivable [Member] | Customer A [Member]
Concentration risk, percentage			13%		15%
Accounts Receivable [Member] | Customer B [Member]
Concentration risk, percentage			7%		8%
Accounts Receivable [Member] | Customer C [Member]
Concentration risk, percentage			17%		0%
Accounts Receivable [Member] | Customer D [Member]
Concentration risk, percentage			0%		9%

Note 5 - Accounts Receivable _5

Note 5 - Accounts Receivable and Revenues - Revenues by Product Line (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues	$ 10,252	$ 6,909	$ 31,001	$ 23,088
UNITED STATES
Revenues	9,876	6,450	30,034	21,867
Other Countries [Member]
Revenues	$ 376	$ 459	$ 967	$ 1,221

Note 6 - Property and Equipme_3

Note 6 - Property and Equipment (Details Textual) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Construction Payable, Current	$ 0.1	$ 0.2
Construction in Progress, Gross	$ 1.1	$ 0.9

Note 6- Property and Equipment

Note 6- Property and Equipment - Property, Plant and Equipment (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Property, plant, and equipment gross	$ 28,969	$ 28,847
Property, plant, and equipment accumulated depreciation	14,340	13,403
Property and equipment, net	14,629	15,444
Land [Member]
Property, plant, and equipment gross	730	730
Furniture and Fixtures [Member]
Property, plant, and equipment gross	$ 259	265
Furniture and Fixtures [Member] | Minimum [Member]
Estimated useful lives (Year)	5 years
Furniture and Fixtures [Member] | Maximum [Member]
Estimated useful lives (Year)	10 years
Plant [Member]
Property, plant, and equipment gross	$ 10,094	10,457
Plant [Member] | Minimum [Member]
Estimated useful lives (Year)	20 years
Plant [Member] | Maximum [Member]
Estimated useful lives (Year)	40 years
Computer and Software [Member]
Property, plant, and equipment gross	$ 450	452
Computer and Software [Member] | Minimum [Member]
Estimated useful lives (Year)	3 years
Computer and Software [Member] | Maximum [Member]
Estimated useful lives (Year)	5 years
Leasehold Improvements [Member]
Property, plant, and equipment gross	$ 1,838	1,828
Leasehold Improvements [Member] | Minimum [Member]
Estimated useful lives (Year)	4 years
Leasehold Improvements [Member] | Maximum [Member]
Estimated useful lives (Year)	15 years
Machinery and Equipment [Member]
Property, plant, and equipment gross	$ 15,598	$ 15,115
Machinery and Equipment [Member] | Minimum [Member]
Estimated useful lives (Year)	5 years
Machinery and Equipment [Member] | Maximum [Member]
Estimated useful lives (Year)	15 years

Note 7 - Leases (Details Textua

Note 7 - Leases (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Finance Lease, Right-of-Use Asset, before Accumulated Amortization	$ 0.9		$ 0.9		$ 0.5
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	0.1	$ 0.1	0.3	$ 0.1
Property and Equipment [Member]
Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total	$ 0.6		$ 0.6		$ 0.2

Note 7 - Leases - Components of

Note 7 - Leases - Components of Lease Expense and Cash Flows from Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Amortization of right-of use assets, included in cost of goods sold	$ 20	$ 24	$ 59	$ 67
Interest on lease liabilities	6	2	11	8
Fixed leases cost	129	129	387	387
Variable lease cost	39	37	125	112
Short-term lease cost	41	21	62	60
Total lease cost	235	213	644	634
Operating cash flows from finance leases	6	2	11	8
Operating cash flows from operating leases	129	129	387	387
Financing cash flows from finance leases	$ 22	$ 23	$ 68	$ 73

Note 7 - Leases - Remaining Ter

Note 7 - Leases - Remaining Terms and Discount Rates (Details)	Sep. 30, 2022
Weighted average remaining lease terms (in years), operating leases (Year)	5 years 8 months 12 days
Weighted average remaining lease terms (in years), finance leases (Year)	3 years
Weighted average discount rate, operating leases	7.80%
Weighted average discount rate, finance leases	8.10%
Minimum [Member]
Remaining leases terms (in years), operating leases (Year)	1 year
Remaining leases terms (in years), finance leases (Year)	4 months 24 days
Discount rates, operating leases	6.30%
Discount rates, finance leases	2.80%
Maximum [Member]
Remaining leases terms (in years), operating leases (Year)	10 years 4 months 24 days
Remaining leases terms (in years), finance leases (Year)	5 years
Discount rates, operating leases	9%
Discount rates, finance leases	10.40%

Note 7 - Leases - Maturities of

Note 7 - Leases - Maturities of Lease Liabilities (Details) $ in Thousands	Sep. 30, 2022 USD ($)
2022, operating leases	$ 122
2022, finance leases	52
2023, operating leases	528
2023, finance leases	158
2024, operating leases	429
2024, finance leases	117
2025, operating leases	440
2025, finance leases	102
2026, operating leases	450
2026, finance leases	100
Thereafter, operating leases	578
Thereafter, finance leases	60
Total lease payments, operating leases	2,547
Total lease payments, finance leases	589
Amounts representing interest, operating leases	(517)
Amounts representing interest, finance leases	(102)
Present value of lease obligations, operating leases	2,030
Present value of lease obligations, finance leases	$ 487

Note 8 - Debt (Details Textual)

Note 8 - Debt (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		10 Months Ended	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Oct. 31, 2019	Dec. 31, 2021
Factoring Agreement [Member] | Line of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity					$ 7,000
Debt Instrument, Term (Year)					2 years
Debt Instrument, Fee Amount					$ 200
Line of Credit Facility, Funding Fee, Percentage Above Prime Rate					0.50%
Line of Credit Facility, Funding Fee, Minimum Percentage					5.50%
Line of Credit Facility, Average Outstanding Amount	$ 3,150	$ 1,522	$ 3,036	$ 1,324
Mortgage Agreement [Member]
Debt Instrument, Interest Rate, Stated Percentage	7%		7%			7%
Proceeds from Issuance of Debt			$ 900
Debt Instrument, Basis Spread on Variable Rate			13.30%			10.30%
Mortgage Agreement [Member] | Prime Rate [Member]
Debt Instrument, Interest Rate, Stated Percentage	10.30%		10.30%
Debt Instrument, Basis Spread on Variable Rate			7%
Debt Instrument, Interest Rate, Effective Percentage	13.30%		13.30%
Line of Credit With Bank [Member]
Debt Instrument, Interest Rate, Effective Percentage	6.30%		6.30%
Long-Term Line of Credit, Total	$ 1,800		$ 1,800
Line of Credit Facility, Average Outstanding Amount	$ 1,500		$ 500
Finance Agreements for Annual Insurance Premiums [Member] | Minimum [Member]
Debt Instrument, Interest Rate, Stated Percentage	3.50%		3.50%
Finance Agreements for Annual Insurance Premiums [Member] | Maximum [Member]
Debt Instrument, Interest Rate, Stated Percentage	3.90%		3.90%

Note 8 - Debt - Due Under Facto

Note 8 - Debt - Due Under Factoring Agreement (Details) - Line of Credit [Member] - Factoring Agreement [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Average borrowings outstanding (in thousands)	$ 3,150	$ 1,522	$ 3,036	$ 1,324
Amortization of debt issuance costs (in thousands)	$ 0	$ 23	$ 0	$ 68
Interest paid, as a percentage of average outstanding borrowings	1.60%	2%	1.40%	5%
Fees paid, as a percentage of average outstanding borrowings	1.60%	1.60%	1.20%	5%

Note 8 - Debt - Long-term Debt

Note 8 - Debt - Long-term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Total long term debt, net	$ 1,698	$ 2,539
Mortgage Agreement [Member]
Total long term debt, net	1,614	2,469
Progress Payment Agreement [Member]
Total long term debt, net	37	0
Equipment Notes, May 2021 [Member] | Notes Payable, Other Payables [Member]
Total long term debt, net	27	33
Equipment Notes, December 2019 [Member] | Notes Payable, Other Payables [Member]
Total long term debt, net	20	26
Equipment Notes, November 2018 [Member]
Total long term debt, net	$ 0	$ 11

Note 8 - Debt - Long-term Deb_2

Note 8 - Debt - Long-term Debt (Details) (Parentheticals) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Issuance costs	$ 10
Mortgage Agreement [Member]
Interest rate	7%	7%
Interest rate, variable	13.30%	10.30%
Issuance costs	$ 11	$ 11
Original principal	$ 2,500	$ 2,500
Maturity date	Dec. 31, 2023	Dec. 31, 2023
Progress Payment Agreement [Member]
Interest rate	25.20%
Original principal	$ 37
Maturity date	Nov. 30, 2022
Equipment Notes, May 2021 [Member] | Notes Payable, Other Payables [Member]
Original principal	$ 46	$ 46
Maturity date	Jun. 30, 2025	Jun. 30, 2025
Interest rate, effective rate	3.60%	3.60%
Equipment Notes, December 2019 [Member] | Notes Payable, Other Payables [Member]
Original principal	$ 40	$ 40
Maturity date	Dec. 31, 2024	Dec. 31, 2024
Interest rate, effective rate	9.30%	9.30%
Equipment Notes, November 2018 [Member]
Maturity date		Aug. 30, 2022
Interest rate, effective rate		4.80%

Note 8 - Debt - Future Principa

Note 8 - Debt - Future Principal Maturities of Long-term Debt Outstanding (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
2022 (three months ended December 31, 2022)	$ 347
2023	1,337
2024	19
2025	5
Principal maturities	1,708
Debt issuance costs	(10)
Long-Term Debt, Total	$ 1,698	$ 2,539

Note 9 - Equity, Share-based _3

Note 9 - Equity, Share-based Compensation and Warrants (Details Textual) - USD ($)				1 Months Ended			3 Months Ended			9 Months Ended
	Nov. 03, 2022	Sep. 30, 2022	Jul. 14, 2022	Oct. 31, 2022	Sep. 30, 2022	Apr. 30, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2022	Apr. 28, 2022	Dec. 31, 2021	Sep. 13, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total (in shares)							2,901	4,455	970
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price (in dollars per share)							$ 19.30	$ 21.42	$ 18.48
Share-based Compensation Arrangement By Share-based Payment Award Options Forfeitures and Expirations, Weighted Average Remaining Contractual Term (Year)							6 years 10 months 24 days	6 years 9 months 18 days	7 years 8 months 12 days
The Warrant [Member]
Class of Warrant or Right, Warrants Expired During Period (in shares)							25,000		614,298
Class of Warrant or Right, Expired, Exercise Price (in dollars per share)							$ 9.60		$ 9.60
Warrant A [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		230,769			230,769		230,769			230,769
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 2.72			$ 2.72		$ 2.72			$ 2.72			$ 10
Subsequent Event [Member]
Proceeds from Issuance or Sale of Equity, Total				$ 1,200,000
Payments of Stock Issuance Costs				$ 300,000
Subsequent Event [Member] | Registered Direct Offering [Member]
Stock Issued During Period, Shares, New Issues (in shares)				675,000
Shares Issued, Price Per Share (in dollars per share)				$ 1.50
Subsequent Event [Member] | The Prefunded Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)				325,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)				$ 0.0001
Class of Warrant or Right, Securities Called by Warrants or Rights, Price per Warrant (in dollars per share)				$ 1.4999
Subsequent Event [Member] | Warrants Issued in Private Placement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)				2,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)				$ 1.60
Subsequent Event [Member] | Placement Agent Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)				63,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)				$ 1.875
Deferred Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)		136,130			136,130		136,130			136,130
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)		434,939			434,939		434,939	96,270	140,128	434,939		126,603
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)							402,276		37,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)								48,386	22,475
Share-based Compensation Arrangement by Share-based Payment Award, Non Option Equity Instruments Impact of Warrant Modification, Prior To Modification (in shares)						11,468		11,468
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Fair Value (in dollars per share)											$ 5.20
Restricted Stock Units (RSUs) [Member] | Director [Member] | Vesting on July 14, 2023 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)			65,790
Restricted Stock Units (RSUs) [Member] | Director [Member] | Immediately Vested [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)		30,279	19,003
Restricted Stock Units (RSUs) [Member] | Employees [Member] | Immediately Vested [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)		9,053
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Month)		8 months
Stock Units [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)		38,968			38,968		38,968	0	0	38,968		0
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)							38,968		0
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)					38,968
Stock Issued During Period, Shares, Restricted Stock Award, Cash Signing Fee		$ 0.2			$ 0.2		$ 0.2			$ 0.2
Aggregate Number of Shares Purchased, Maximum (in shares)										1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Non Option Equity Instruments Impact of Warrant Modification, Prior To Modification (in shares)								0
Stock Units [Member] | Subsequent Event [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)	121,032
Modified RSUs [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)								11,468
The 2014 Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)			600,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)		228,201			228,201		228,201			228,201
The 2014 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)			278,151
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Month)			49 months

Note 9 - Equity, Share-based _4

Note 9 - Equity, Share-based Compensation and Warrants - Stockholders Equity (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Balance (in shares)			5,158,967				5,158,967
Balance	$ 14,751	$ 17,225	$ 18,495	$ 22,807	$ 24,261	$ 23,420	$ 18,495	$ 23,420
Common stock awards under equity incentive plans	492	146	241	287	290	250
Common stock issued to vendor	2	1	5	5	5	3
Net income (loss)	(2,042)	(2,621)	(1,516)	(2,213)	(1,923)	591	(6,179)	(3,545)
Net income (loss)	$ (2,042)	(2,621)	(1,516)	(2,213)	(1,923)	591	$ (6,179)	(3,545)
Balance (in shares)	5,242,077						5,242,077
Balance	$ 13,203	14,751	17,225	23,611	22,807	24,261	$ 13,203	23,611
Other					3	(3)
Exercise of common stock warrants				0	171
Sale of common stock and common stock warrants, net of costs				2,725
Conversion of preferred stock into common stock				0
Preferred Stock [Member]
Balance	75	75	75	112	112	112	75	112
Common stock awards under equity incentive plans	0	0	0	0	0	0
Common stock issued to vendor	0	0	0	0	0	0
Net income (loss)	0	0	0	0	0	0
Net income (loss)	0	0	0	0	0	0
Balance	$ 75	$ 75	$ 75	75	112	112	$ 75	$ 75
Other					0	$ 0
Exercise of common stock warrants				0	$ 0
Sale of common stock and common stock warrants, net of costs				0
Conversion of preferred stock into common stock				$ (37)
Preferred Stock [Member] | Series G Preferred Stock [Member]
Balance (in shares)	150	150	150	225	225	225	150	225
Common stock awards under equity incentive plans (in shares)	0	0	0	0	0	0
Common stock issued to vendor (in shares)	0	0	0	0	0	0
Other (in shares)	0
Balance (in shares)	150	150	150	150	225	225	150	150
Exercise of common stock warrants (in shares)				0	0
Sale of common stock and common stock warrants, net of costs (in shares)				0
Conversion of preferred stock into common stock (in shares)				(75)
Common Stock [Member]
Balance (in shares)	5,231,030	5,182,042	5,158,967	4,548,761	4,527,403	4,523,809	5,158,967	4,523,809
Balance	$ 326,672	$ 326,525	$ 326,279	$ 322,937	$ 322,468	$ 322,218	$ 326,279	$ 322,218
Common stock awards under equity incentive plans (in shares)		48,388	22,475	38,978	2,964	2,994
Common stock awards under equity incentive plans	$ 492	$ 146	$ 241	$ 287	$ 290	$ 250
Common stock issued to vendor (in shares)	600	600	600	600	600	600
Common stock issued to vendor	$ 2	$ 1	$ 5	$ 5	$ 5	$ 3
Net income (loss)	0	0	0	0	0	0
Net income (loss)	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Other (in shares)	10,447
Balance (in shares)	5,242,077	5,231,030	5,182,042	9,221,908	4,548,761	4,527,403	5,242,077	9,221,908
Balance	$ 327,166	$ 326,672	$ 326,525	$ 325,991	$ 322,937	$ 322,468	$ 327,166	$ 325,991
Other					$ 3	(3)
Exercise of common stock warrants (in shares)				1,500,000	17,794
Exercise of common stock warrants				$ 0	$ 171
Sale of common stock and common stock warrants, net of costs (in shares)				3,062,395
Sale of common stock and common stock warrants, net of costs				$ 2,725
Conversion of preferred stock into common stock (in shares)				71,174
Conversion of preferred stock into common stock				$ 37
Retained Earnings [Member]
Balance	(311,996)	(309,375)	(307,859)	(300,242)	(298,319)	(298,910)	(307,859)	(298,910)
Common stock awards under equity incentive plans	0	0	0	0	0	0
Common stock issued to vendor	0	0	0	0	0	0
Net income (loss)	(2,042)	(2,621)	(1,516)	(2,213)	(1,923)	591
Net income (loss)	(2,042)	(2,621)	(1,516)	(2,213)	(1,923)	591
Balance	$ (314,038)	$ (311,996)	$ (309,375)	(302,455)	(300,242)	(298,319)	$ (314,038)	$ (302,455)
Other					0	$ 0
Exercise of common stock warrants				0	$ 0
Sale of common stock and common stock warrants, net of costs				0
Conversion of preferred stock into common stock				$ 0

Note 9 - Equity, Share-based _5

Note 9 - Equity, Share-based Compensation and Warrants - Share-based Compensation Expenses Related to Employees and Directors (Details) - The 2014 Equity Incentive Plan [Member] - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Compensation expense related to common stock awards issued under equity incentive plans	$ 492	$ 146	$ 241
Share-Based Payment Arrangement, Option [Member]
Compensation expense related to common stock awards issued under equity incentive plans	28	21	29
Restricted Stock Units (RSUs) [Member]
Compensation expense related to common stock awards issued under equity incentive plans	$ 464	$ 125	$ 212

Note 9 - Equity, Share-based _6

Note 9 - Equity, Share-based Compensation and Warrants - Restricted Stock Unit Activity (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Apr. 30, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Restricted Stock Units (RSUs) [Member]
Nonvested, shares issued (in shares)	140,128	96,270	140,128	126,603
Nonvested, unrecognized stock compensation	$ (592)	$ (347)	$ (592)	$ (658)
Nonvested (Year)		2 years 6 months	10 months 24 days	10 months 24 days
Granted, nonvested, shares issued (in shares)		402,276		37,000
Granted, unrecognized stock compensation		$ (1,458)		$ (153)
Granted (Year)		2 years 9 months 18 days		2 years
Forfeited, shares issued (in shares)			(9,454)	(1,000)
Forfeited, unrecognized stock compensation			$ 55	$ 7
Forfeited (Year)				8 months 12 days
Forfeited, unrecognized stock compensation			$ 55	$ 7
Vested with Service, shares issued (in shares)		(63,607)	(34,404)	(22,475)
Expensed, unrecognized stock compensation		$ 464	$ 125	$ 212
Before modification, shares issued (in shares)	(11,468)		(11,468)
Before modification, unrecognized stock compensation			$ 125
After modificaiton, shares issued (in shares)			11,468
After modificaiton, unrecognized stock compensation			$ (60)
Nonvested, shares issued (in shares)		434,939	96,270	140,128
Nonvested, unrecognized stock compensation		$ (1,341)	$ (347)	$ (592)
Vested, balance (in shares)	86,505	72,523	86,505	86,505
Vested with service (in shares)		63,607	34,404	22,475
Issued at vesting (in shares)				(22,475)
Issued at termination of service (in shares)			(48,386)
Vested, balance (in shares)		136,130	72,523	86,505
Stock Units [Member]
Nonvested, shares issued (in shares)	0	0	0	0
Nonvested, unrecognized stock compensation	$ 0	$ 0	$ 0	$ 0
Nonvested (Year)		3 years
Granted, nonvested, shares issued (in shares)		38,968		0
Granted, unrecognized stock compensation		$ (65)		$ 0
Granted (Year)		3 years
Forfeited, shares issued (in shares)			0	0
Forfeited, unrecognized stock compensation			$ 0	$ 0
Forfeited, unrecognized stock compensation			$ 0	$ 0
Vested with Service, shares issued (in shares)		0	0	0
Expensed, unrecognized stock compensation		$ 0	$ 0	$ 0
Before modification, shares issued (in shares)			0
Before modification, unrecognized stock compensation			$ 0
After modificaiton, shares issued (in shares)			0
After modificaiton, unrecognized stock compensation			$ 0
Nonvested, shares issued (in shares)		38,968	0	0
Nonvested, unrecognized stock compensation		$ (65)	$ 0	$ 0
Vested with service (in shares)		0	0	0

Note 11 - Loss Per Share (EPS_2

Note 11 - Loss Per Share (EPS) - EPS Compensations (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Net income (loss)	$ (2,042)	$ (2,621)	$ (1,516)	$ (2,213)	$ (1,923)	$ 591	$ (6,179)	$ (3,545)
Weighted average number of shares of shares of common stock outstanding (in shares)	5,235,005			4,662,004			5,203,504	4,575,587
Weighted average number of shares of common stock underlying vested RSUs (in shares)	97,303			83,680			87,276	56,293
Denominator for basic and diluted EPS - weighted average number of shares outstanding (in shares)	5,332,308			4,745,684			5,290,780	4,631,880

Note 12 - Fair Value Measurem_3

Note 12 - Fair Value Measurements (Details Textual) $ / shares in Units, $ in Thousands		9 Months Ended
	Sep. 13, 2021 $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021
Warrant A [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares		230,769
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 10	$ 2.72
Warrant A [Member] | Derivative Financial Instruments, Liabilities [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares	230,769
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 10	$ 2.72
Class of Warrant or Right, Change in Exercise Price, Maximum Percentage of Five-day Volume Weighted Average Common Stock	110%
Warrants and Rights Outstanding, Measurement Input		2.72
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Operating Lease, Fair Value In Excess Of Carrying Amount | $		$ 500
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Measurement Input, Exercise Price [Member]
Warrants and Rights Outstanding, Measurement Input			10
Warrant, Exercise Price, Increase (in dollars per share)		$ 0.18
Warrant, Exercise Price, Increased Percentage		10%
Fair Value Adjustment of Warrants | $		$ 32

Note 12 - Fair Value Measurem_4

Note 12 - Fair Value Measurement - Fair Value of Liabilities on Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Total liabilities at fair value as of September 30, 2022 - Derivative warrant liability	$ 234	$ 258	$ 647
Fair Value, Inputs, Level 1 [Member]
Total liabilities at fair value as of September 30, 2022 - Derivative warrant liability	0	0	0
Fair Value, Inputs, Level 2 [Member]
Total liabilities at fair value as of September 30, 2022 - Derivative warrant liability	0	0	0
Fair Value, Inputs, Level 3 [Member]
Total liabilities at fair value as of September 30, 2022 - Derivative warrant liability	$ 234	$ 258	$ 647

Note 12 - Fair Value Measurem_5

Note 12 - Fair Value Measurement - Changes in Level 3 Items Measured at Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Fair value, balance	$ 846	$ 258	$ 0
Total realized and unrealized gains (losses	612	24	0
Issuance of new instruments	0	0	647
Net transfers (into) out of level 3	0	0	0
Fair value, balance	234	234	647
Change in unrealized gains (losses) on instruments still held	$ 612	$ 24	$ 0

Note 12 - Fair Value Measurem_6

Note 12 - Fair Value Measurement - Fair Value Assumption Measurement of Warrant A (Details)	Sep. 30, 2022	Dec. 31, 2021
Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input	88.3	69.5
Measurement Input, Risk Free Interest Rate [Member]
Warrants and Rights Outstanding, Measurement Input	0.032	0.008
Measurement Input, Expected Term [Member]
Warrants and Rights Outstanding, Measurement Input	4	4.8
Measurement Input, Expected Dividend Rate [Member]
Warrants and Rights Outstanding, Measurement Input	0	0

Note 13 - Commitments and Con_2

Note 13 - Commitments and Contingencies (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Apr. 30, 2020
Long-Term Debt, Total	$ 1,698	$ 2,539
Paycheck Protection Program CARES Act [Member]
Long-Term Debt, Total			$ 1,800